Pathology and Pathogenesis of Chagas Heart Disease

Kevin M. Bonney, Daniel J. Luthringer, Stacey A. Kim, Nisha Garg, David M. Engman

    Research output: Contribution to journalReview article

    9 Citations (Scopus)

    Abstract

    Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T. cruzi is transmitted to people is through contact with infected kissing bugs, which are found in much of the Western Hemisphere, including in vast areas of the United States. The epidemiology of T. cruzi and Chagas heart disease and the varied mechanisms leading to myocyte destruction, mononuclear cell infiltration, fibrosis, and edema in the heart have been extensively studied by hundreds of scientists for more than 100 years. Despite this wealth of knowledge, it is still impossible to predict what will happen in an individual infected with T. cruzi because of the tremendous variability in clonal parasite virulence and human susceptibility to infection and the lack of definitive molecular predictors of outcome from either side of the host-parasite equation. Further, while several distinct mechanisms of pathogenesis have been studied in isolation, it is certain that multiple coincident mechanisms combine to determine the ultimate outcome. For these reasons, Chagas disease is best considered a collection of related but distinct illnesses. This review highlights the pathology and pathogenesis of the most common adverse sequela of T. cruzi infection - Chagas heart disease - and concludes with a discussion of key unanswered questions and a view to the future.

    Original languageEnglish (US)
    Pages (from-to)421-447
    Number of pages27
    JournalAnnual Review of Pathology: Mechanisms of Disease
    Volume14
    DOIs
    StatePublished - Jan 1 2019

    Fingerprint

    Chagas Disease
    Trypanosoma cruzi
    Heart Diseases
    Pathology
    Parasites
    Infection
    Cardiomyopathies
    Muscle Cells
    Virulence
    Edema
    Epidemiology
    Fibrosis

    Keywords

    • Chagas, heart, trypanosome, myocarditis, cardiomyopathy, pathogenesis

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine

    Cite this

    Pathology and Pathogenesis of Chagas Heart Disease. / Bonney, Kevin M.; Luthringer, Daniel J.; Kim, Stacey A.; Garg, Nisha; Engman, David M.

    In: Annual Review of Pathology: Mechanisms of Disease, Vol. 14, 01.01.2019, p. 421-447.

    Research output: Contribution to journalReview article

    Bonney, Kevin M. ; Luthringer, Daniel J. ; Kim, Stacey A. ; Garg, Nisha ; Engman, David M. / Pathology and Pathogenesis of Chagas Heart Disease. In: Annual Review of Pathology: Mechanisms of Disease. 2019 ; Vol. 14. pp. 421-447.
    @article{486b9a2f8e6d462aa9e05e1ec235e208,
    title = "Pathology and Pathogenesis of Chagas Heart Disease",
    abstract = "Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T. cruzi is transmitted to people is through contact with infected kissing bugs, which are found in much of the Western Hemisphere, including in vast areas of the United States. The epidemiology of T. cruzi and Chagas heart disease and the varied mechanisms leading to myocyte destruction, mononuclear cell infiltration, fibrosis, and edema in the heart have been extensively studied by hundreds of scientists for more than 100 years. Despite this wealth of knowledge, it is still impossible to predict what will happen in an individual infected with T. cruzi because of the tremendous variability in clonal parasite virulence and human susceptibility to infection and the lack of definitive molecular predictors of outcome from either side of the host-parasite equation. Further, while several distinct mechanisms of pathogenesis have been studied in isolation, it is certain that multiple coincident mechanisms combine to determine the ultimate outcome. For these reasons, Chagas disease is best considered a collection of related but distinct illnesses. This review highlights the pathology and pathogenesis of the most common adverse sequela of T. cruzi infection - Chagas heart disease - and concludes with a discussion of key unanswered questions and a view to the future.",
    keywords = "Chagas, heart, trypanosome, myocarditis, cardiomyopathy, pathogenesis",
    author = "Bonney, {Kevin M.} and Luthringer, {Daniel J.} and Kim, {Stacey A.} and Nisha Garg and Engman, {David M.}",
    year = "2019",
    month = "1",
    day = "1",
    doi = "10.1146/annurev-pathol-020117-043711",
    language = "English (US)",
    volume = "14",
    pages = "421--447",
    journal = "Annual Review of Phytopathology",
    issn = "1553-4006",
    publisher = "Annual Reviews Inc.",

    }

    TY - JOUR

    T1 - Pathology and Pathogenesis of Chagas Heart Disease

    AU - Bonney, Kevin M.

    AU - Luthringer, Daniel J.

    AU - Kim, Stacey A.

    AU - Garg, Nisha

    AU - Engman, David M.

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T. cruzi is transmitted to people is through contact with infected kissing bugs, which are found in much of the Western Hemisphere, including in vast areas of the United States. The epidemiology of T. cruzi and Chagas heart disease and the varied mechanisms leading to myocyte destruction, mononuclear cell infiltration, fibrosis, and edema in the heart have been extensively studied by hundreds of scientists for more than 100 years. Despite this wealth of knowledge, it is still impossible to predict what will happen in an individual infected with T. cruzi because of the tremendous variability in clonal parasite virulence and human susceptibility to infection and the lack of definitive molecular predictors of outcome from either side of the host-parasite equation. Further, while several distinct mechanisms of pathogenesis have been studied in isolation, it is certain that multiple coincident mechanisms combine to determine the ultimate outcome. For these reasons, Chagas disease is best considered a collection of related but distinct illnesses. This review highlights the pathology and pathogenesis of the most common adverse sequela of T. cruzi infection - Chagas heart disease - and concludes with a discussion of key unanswered questions and a view to the future.

    AB - Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T. cruzi is transmitted to people is through contact with infected kissing bugs, which are found in much of the Western Hemisphere, including in vast areas of the United States. The epidemiology of T. cruzi and Chagas heart disease and the varied mechanisms leading to myocyte destruction, mononuclear cell infiltration, fibrosis, and edema in the heart have been extensively studied by hundreds of scientists for more than 100 years. Despite this wealth of knowledge, it is still impossible to predict what will happen in an individual infected with T. cruzi because of the tremendous variability in clonal parasite virulence and human susceptibility to infection and the lack of definitive molecular predictors of outcome from either side of the host-parasite equation. Further, while several distinct mechanisms of pathogenesis have been studied in isolation, it is certain that multiple coincident mechanisms combine to determine the ultimate outcome. For these reasons, Chagas disease is best considered a collection of related but distinct illnesses. This review highlights the pathology and pathogenesis of the most common adverse sequela of T. cruzi infection - Chagas heart disease - and concludes with a discussion of key unanswered questions and a view to the future.

    KW - Chagas, heart, trypanosome, myocarditis, cardiomyopathy, pathogenesis

    UR - http://www.scopus.com/inward/record.url?scp=85060546185&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85060546185&partnerID=8YFLogxK

    U2 - 10.1146/annurev-pathol-020117-043711

    DO - 10.1146/annurev-pathol-020117-043711

    M3 - Review article

    C2 - 30355152

    AN - SCOPUS:85060546185

    VL - 14

    SP - 421

    EP - 447

    JO - Annual Review of Phytopathology

    JF - Annual Review of Phytopathology

    SN - 1553-4006

    ER -